As neurology enters the era of high-cost therapies, financial toxicity is becoming a key determinant of access, adherence, and equity.
Proud to work with superstar resident Dr. Gotlieb on this viewpoint in @greenjournal.bsky.social
neurology.org/doi/full/10....
@mskcancercenter.bsky.social
